Company news

Connecting the life sciences: Marburg meets Mainz

Partnerships do not happen overnight – they grow through exchange, dialogue and a shared vision for the future.

Reduction of F-gases

With the new EU Regulation on fluorinated greenhouse gases (F-gases), the reduction of these gases is taking center stage more than ever. As an experienced operator of Pharma & Life Science Parks in Europe, INNEXIS guides companies safely through this transition.

A new hub for biotech innovation in Europe

Through the targeted expansion of the Orth Pharma & Life Science Park on the Danube, INNEXIS is developing a new European hub for biotech and pharmaceutical innovation. Located in the heart of Europe, between Vienna and Bratislava, the site effectively connects international companies, startups, research institutions, and public partners.

INNEXIS – Strong presence at two important industry events

Lounges in Karlsruhe and PharmaTechnica in Wiesbaden – in March 2026, we will be there for our customers where it matters most for the pharmaceutical and cleanroom world.

INNEXIS Pharma Shop

Your solution for efficient procurement in pharmaceuticals and life sciences: Our Pharma Shop offers a wide range of laboratory and production items, hygiene products and personal protective equipment – all specially tailored to the requirements of the pharmaceutical and life sciences industries.

From Infrareal and Pharmaserv to INNEXIS

INNEXIS unites its services under one umbrella brand to strengthen its presence among customers and stakeholders.

INNEXIS ensures ultrapure water quality

It is checked whether the measuring devices correctly record the organic carbon content in the water.

INNEXIS establishes consignment warehouse

INNEXIS establishes consignment warehouse for Picea Biosolutions at the new site in Offenburg.

Infrareal takes over Takeda’s pharmaceutical and biotech site in Orth

Through its subsidiary PharmaparkOrth Management GmbH, Infrareal is acquiring the 24-hectare site from Takeda including buildings, infrastructure and several pharmaceutical production facilities.